Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms Underlying Stem Cell Educator Therapy for the Treatment of Diabetes

NCT03390231 is registered in ClinicalTrials.gov with Throne Biotechnologies Inc. as lead sponsor.

NCT NCT03390231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03390231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms Underlying Stem Cell Educator Therapy for the Treatment of Diabetes
Lead sponsor
Throne Biotechnologies Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
November 27, 2017
Completion date
December 31, 2020
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 1, diabetes mellitus, type 2